Vallejo, CANCT07195695Now EnrollingIRB Ready

Non-small Cell Lung Cancer Clinical Trial in Vallejo, CA

Access cutting-edge non-small cell lung cancer treatment through this phase 3 clinical trial at a research site in Vallejo. Study-provided care at no cost to qualified participants.

Sponsored by Boehringer Ingelheim

Quick Self-Assessment

See if you qualify for this Vallejo location

Preparing your pre-screening questions…

Expert Care in Vallejo

Access non-small cell lung cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related non-small cell lung cancer treatment provided free

Apply for This Vallejo Location

Check if you qualify for this non-small cell lung cancer clinical trial in Vallejo, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Vallejo

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Vallejo site if eligible
  4. 4Begin participation

About This Non-small Cell Lung Cancer Study in Vallejo

This study is open to adults 18 years and older who have early-stage non-small cell lung cancer (NSCLC). Their cancer must have a specific change in a gene called HER2. Genes provide the instructions for making proteins, and this change leads to a faulty HER2 protein. People can join if their lung cancer was removed by surgery, and they have already received certain other anti-cancer treatments. The purpose of this study is to find out if a study medicine called zongertinib helps people with thi

Sponsor: Boehringer Ingelheim

Who Can Participate

Inclusion Criteria

Signed and dated written informed consent in accordance with ICH-GCP and local legislation prior to admission to the trial
Patients must be ≥18 years old or over the legal age of consent in their country
Male or female patients. Women of childbearing potential (WOCBP) must be ready and able to use dual highly effective methods of birth control per ICH M3 (R2) that result in a low failure rate of less than 1% per year when used consistently and correctly. A list of contraception methods meeting these criteria is provided in the patient information and in the study protocol
HER2 mutation: Documented Tyrosine kinase domain (TKD) activating Human epidermal growth factor receptor 2 (HER2) mutations
Histology and tumor sample: Histologically confirmed diagnosis of primary NSCLC
An archival tumor tissue sample must be submitted to the central laboratory after inclusion of the patient to retrospectively confirm the HER2 status
Staging: Pretherapeutic classification not exceeding Stage IIIB
Performance status and organ function:
Eastern Cooperative Oncology Group (ECOG) score of 0 or 1
Adequate organ function based on laboratory values Further inclusion criteria apply.

Exclusion Criteria

Diagnosis of NSCLC with mixed histology/positive neuroendocrine markers (synaptophysin/CD56)
Major surgery (major according to the investigator's assessment) performed within 4 weeks prior to randomization
Treatment with radiation therapy for primary NSCLC
Co-occurring actionable mutation with approved targeted therapy (e.g. Epidermal growth factor receptor (EGFR) or Anaplastic lymphoma kinase (ALK))
Any investigational drug within 5 half-lives of the compound or any of its related material, if known
History or presence of
Active or known pre-existing or history of non-infectious interstitial lung disease/pneumonitis
Active infectious disease requiring systemic therapy
Uncontrolled gastrointestinal disorders affecting drug intake/absorption
Previous or concomitant malignancies within the last 3 years, except certain effectively treated cancers
Significant and/or uncontrolled cardiovascular abnormalities, QT interval corrected for heart rate by Fridericia formula (QTcF) \>470 msec, or ejection fraction \<50% Further exclusion criteria apply.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Vallejo?

Yes, this clinical trial (NCT07195695) has an active research site in Vallejo, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Non-small Cell Lung Cancer Treatment Options in Vallejo, CA

If you're searching for non-small cell lung cancer treatment options in Vallejo, CA, this clinical trial (NCT07195695) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Vallejo research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced non-small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all non-small cell lung cancer clinical trials near you to find additional studies recruiting in your area.

More Lung Cancer Trials in Vallejo, CA

See all lung cancer clinical trials recruiting in Vallejo — not just this study.

Browse Lung Cancer Trials in Vallejo →

Browse More Trials by Condition

Lung Cancer TrialsLeukemia TrialsSmall Cell Lung Cancer TrialsNon-Small Cell Lung Cancer TrialsSpinal Muscular Atrophy TrialsAll Conditions →

Ready to Join in Vallejo?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Vallejo, CA